Literature DB >> 2451678

Enzyme immunoassay for detection of human immunodeficiency virus antigens in cell cultures.

R Viscidi1, H Farzadegan, F Leister, M L Francisco, R Yolken.   

Abstract

A sensitive and specific avidin-biotin enzyme immunoassay that uses immunoreagents from naturally infected individuals was formulated for the detection of human immunodeficiency virus (HIV) antigens. A total of 500 cell culture samples from 111 cultures were tested in this assay and in a reverse transcriptase (RT) assay. Of 353 samples that were positive in the immunoassay, 174 were positive and 179 were negative in the RT assay. The specificity of the immunoassay results was supported by the failure of samples to react with nonimmune serum, by the ability of an anti-HIV type 1 monoclonal antibody to block the reactivity of selected samples, and by the appearance of RT activity in samples drawn from some cultures after a longer period of cultivation. HIV antigens were detected in 174 of 176 RT-positive samples (sensitivity, 98.9%). A comparison of the kinetics of antigen production and RT activity revealed that detectable antigen levels frequently preceded the appearance of RT activity. Thus, 50% of virus-containing cultures were identified within 9 days by immunoassay compared with 14 days by RT assay. In addition, RT activity was often detected intermittently in cultures sampled on several days, whereas antigen levels did not decline after initial appearance. Enzyme immunoassays for HIV antigen detection that use easily obtained reagents and simple technologies could facilitate laboratory and clinical research which requires cultivation of viruses.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2451678      PMCID: PMC266312          DOI: 10.1128/jcm.26.3.453-458.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Recovery of AIDS-associated retroviruses from patients with AIDS or AIDS-related conditions and from clinically healthy individuals.

Authors:  J A Levy; J Shimabukuro
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

2.  Detection of human T-cell lymphotropic virus type III-related antigens and anti-human T-cell lymphotropic virus type III antibodies by anticomplementary immunofluorescence.

Authors:  R S Blumberg; E G Sandstrom; T J Paradis; D N Neumeyer; M G Sarngadharan; K L Hartshorn; R E Byington; M S Hirsch; R T Schooley
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

3.  Detection and differentiation by sandwich enzyme-linked immunosorbent assay of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus- and acquired immunodeficiency syndrome-associated retroviruslike clinical isolates.

Authors:  J R Higgins; N C Pedersen; J R Carlson
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

4.  Serological markers in early stages of human immunodeficiency virus infection in haemophiliacs.

Authors:  J P Allain; Y Laurian; D A Paul; D Senn
Journal:  Lancet       Date:  1986-11-29       Impact factor: 79.321

5.  Visual reading of enzyme immunofluorescence assays for human cytomegalovirus antibodies.

Authors:  B Forghani; J Dennis; N J Schmidt
Journal:  J Clin Microbiol       Date:  1980-11       Impact factor: 5.948

Review 6.  Enzyme immunoassays for the detection of infectious antigens in body fluids: current limitations and future prospects.

Authors:  R H Yolken
Journal:  Rev Infect Dis       Date:  1982 Jan-Feb

7.  The use of avidin-biotin interaction in immunoenzymatic techniques.

Authors:  J L Guesdon; T Ternynck; S Avrameas
Journal:  J Histochem Cytochem       Date:  1979-08       Impact factor: 2.479

8.  Molecular cloning and polymorphism of the human immune deficiency virus type 2.

Authors:  F Clavel; M Guyader; D Guétard; M Sallé; L Montagnier; M Alizon
Journal:  Nature       Date:  1986 Dec 18-31       Impact factor: 49.962

9.  Detection of human immunodeficiency virus by reverse transcriptase assay, antigen capture assay, and radioimmunoassay.

Authors:  P Gupta; R Balachandran; K Grovit; D Webster; C Rinaldo
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

10.  Identification of human immunodeficiency virus sequences by using in vitro enzymatic amplification and oligomer cleavage detection.

Authors:  S Kwok; D H Mack; K B Mullis; B Poiesz; G Ehrlich; D Blair; A Friedman-Kien; J J Sninsky
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

View more
  6 in total

1.  Passive hemagglutination test for detection of antibodies to human immunodeficiency virus type 1 and comparison of the test with enzyme-linked immunosorbent assay and Western blot (immunoblot) analysis.

Authors:  M B Vasudevachari; K W Uffelman; T C Mast; R L Dewar; V Natarajan; H C Lane; N P Salzman
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

2.  Monoclonal antibody solution hybridization assay for detection of human immunodeficiency virus nucleic acids.

Authors:  R P Viscidi; C O'Meara; H Farzadegan; R Yolken
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

3.  New Phosphorus Analogs of Bevirimat: Synthesis, Evaluation of Anti-HIV-1 Activity and Molecular Docking Study.

Authors:  Elwira Chrobak; Krzysztof Marciniec; Aleksandra Dąbrowska; Paweł Pęcak; Ewa Bębenek; Monika Kadela-Tomanek; Andrzej Bak; Maria Jastrzębska; Stanisław Boryczka
Journal:  Int J Mol Sci       Date:  2019-10-21       Impact factor: 5.923

Review 4.  Antigen detection for human immunodeficiency virus.

Authors:  D J Harry; M B Jennings; J Yee; J R Carlson
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

5.  Analysis of ovine lentivirus infectivity and replication by using a focal immunoassay and an antigen-capture enzyme-linked immunosorbent assay.

Authors:  K A Marcom; S J Brodie; L D Pearson; J C DeMartini
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

Review 6.  The diagnosis of human immunodeficiency virus infection: progress in less than five years.

Authors:  F J Michalski
Journal:  Yale J Biol Med       Date:  1989 Mar-Apr
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.